Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4OVE

X-ray Crystal Structure of Mouse Netrin-1

Summary for 4OVE
Entry DOI10.2210/pdb4ove/pdb
DescriptorNetrin-1, alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (7 entities in total)
Functional Keywordssimilar to laminin gamma-1, domain vi: beta-sandwich jelly-roll, domains v-1, v-2, v-3: laminin-type epidermal growth factor, structural calcium, axon guidance cue, survival factor, neogenin, dcc, unc5a, unc5b, unc5c, unc5d, dscam, extracellular matrix, apoptosis
Biological sourceMus musculus (mouse)
Total number of polymer chains1
Total formula weight50626.25
Authors
Meier, M.,Nikodemus, D.,Reuten, R.,Patel, T.R.,Orriss, G.,Okun, N.,Koch, M.,Stetefeld, J. (deposition date: 2014-02-21, release date: 2015-02-25, Last modification date: 2024-10-30)
Primary citationGrandin, M.,Meier, M.,Delcros, J.G.,Nikodemus, D.,Reuten, R.,Patel, T.R.,Goldschneider, D.,Orriss, G.,Krahn, N.,Boussouar, A.,Abes, R.,Dean, Y.,Neves, D.,Bernet, A.,Depil, S.,Schneiders, F.,Poole, K.,Dante, R.,Koch, M.,Mehlen, P.,Stetefeld, J.
Structural Decoding of the Netrin-1/UNC5 Interaction and its Therapeutical Implications in Cancers.
Cancer Cell, 29:173-185, 2016
Cited by
PubMed Abstract: Netrin-1 has been shown to be up-regulated in a fraction of human cancers as a mechanism to allow these tumors to escape the pro-apoptotic activity of some of its main dependence receptors, the UNC5 homologs (UNC5H). Here we identify the V-2 domain of netrin-1 to be important for its interaction with the Ig1/Ig2 domains of UNC5H2. We generate a humanized anti-netrin-1 antibody that disrupts the interaction between netrin-1 and UNC5H2 and triggers death of netrin-1-expressing tumor cells in vitro. We also present evidence that combining the anti-netrin-1 antibody with epidrugs such as decitabine could be effective in treating tumors showing no or modest netrin-1 expression. These results support that this antibody is a promising drug candidate.
PubMed: 26859457
DOI: 10.1016/j.ccell.2016.01.001
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.64 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon